Pages that link to "Q28272697"
Jump to navigation
Jump to search
The following pages link to APO2 ligand: a novel lethal weapon against malignant glioma? (Q28272697):
Displaying 50 items.
- Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector (Q31087174) (← links)
- Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis (Q33378957) (← links)
- Safety and antitumor activity of recombinant soluble Apo2 ligand (Q33855449) (← links)
- APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis (Q34090695) (← links)
- mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells (Q34097241) (← links)
- Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo (Q34132999) (← links)
- Apoptosis in oncology (Q34220661) (← links)
- Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells (Q34272896) (← links)
- Shared pathways: death receptors and cytotoxic drugs in cancer therapy (Q34310555) (← links)
- APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo (Q34722539) (← links)
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (Q34791120) (← links)
- Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. (Q35020357) (← links)
- Oncolytic Vesicular Stomatitis Virus Induces Apoptosis in U87 Glioblastoma Cells by a Type II Death Receptor Mechanism and Induces Cell Death and Tumor Clearance In Vivo (Q35077031) (← links)
- Cell surface Death Receptor signaling in normal and cancer cells (Q35091128) (← links)
- Current and future strategies for the treatment of malignant brain tumors. (Q35095713) (← links)
- Detection of Anticancer and Apoptotic Effect of the Produced IgYs against the Three Extracellular Domain of Human DR5 Protein (Q35543789) (← links)
- Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma (Q35678312) (← links)
- TRAIL and chemotherapeutic drugs in cancer therapy (Q35756909) (← links)
- TRAIL and malignant glioma. (Q35756919) (← links)
- Update on herpesvirus amplicon vectors (Q35903203) (← links)
- Apoptosis in gliomas: molecular mechanisms and therapeutic implications (Q36021584) (← links)
- Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle (Q36118431) (← links)
- Immunochemical characteristics of a novel cell death receptor and a decoy receptor on granulosa cells of porcine ovarian follicles (Q36304619) (← links)
- Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma (Q36470507) (← links)
- Functional screening of genes suppressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-XL and Bcl-2. (Q36648820) (← links)
- Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas (Q36695971) (← links)
- In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs. (Q36786006) (← links)
- Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide (Q37356520) (← links)
- Antitumor activity of TRAIL recombinant adenovirus in human malignant glioma cells (Q37425788) (← links)
- microRNAs in gliomas: small regulators of a big problem (Q37592046) (← links)
- Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics (Q37761935) (← links)
- TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new? (Q38070361) (← links)
- Encapsulated stem cells for cancer therapy (Q38090923) (← links)
- Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). (Q38673432) (← links)
- Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer (Q38807560) (← links)
- Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas (Q38869957) (← links)
- Urokinase-type plasminogen activator receptor regulates apoptotic sensitivity of colon cancer HCT116 cell line to TRAIL via JNK-p53 pathway (Q38967029) (← links)
- The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells (Q38981224) (← links)
- Neural stem cell-based gene therapy for brain tumors (Q39137284) (← links)
- Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. (Q39162763) (← links)
- Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin (Q39710105) (← links)
- Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells (Q39923672) (← links)
- Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins (Q39956386) (← links)
- Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. (Q40002391) (← links)
- A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis (Q40023794) (← links)
- Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma (Q40070342) (← links)
- Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression (Q40070572) (← links)
- Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling (Q40158789) (← links)
- TRAIL-induced apoptosis in U-1242 MG glioma cells (Q40319830) (← links)
- Cancer gene therapy using a novel secretable trimeric TRAIL. (Q40367155) (← links)